Cargando…
The Subjective Experience of Using Medications: What We Know and the Paths Forward
Medications can cause bodily changes, where the associated benefits and risks are carefully assessed based on the changes experienced in the phenomenal body. For this reason, the phenomenology of Merleau-Ponty is an important theoretical framework for the study of experience related to the daily use...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006003/ https://www.ncbi.nlm.nih.gov/pubmed/33801298 http://dx.doi.org/10.3390/pharmacy9010050 |
_version_ | 1783672227179266048 |
---|---|
author | de Almeida Nascimento, Yone Ramalho-de-Oliveira, Djenane |
author_facet | de Almeida Nascimento, Yone Ramalho-de-Oliveira, Djenane |
author_sort | de Almeida Nascimento, Yone |
collection | PubMed |
description | Medications can cause bodily changes, where the associated benefits and risks are carefully assessed based on the changes experienced in the phenomenal body. For this reason, the phenomenology of Merleau-Ponty is an important theoretical framework for the study of experience related to the daily use of medications. The aim of this study was to discuss the contribution of a recently developed framework of the general ways people can experience the daily use of medications—resolution, adversity, ambiguity, and irrelevance—and present reflections about the little-understood aspects of this experience. However, some issues raised throughout this article remain open and invite us to further exploration, such as (1) the coexistence of multiple ways of experiencing the use of medications, by the same individual, in a given historical time; (2) the cyclical structure of this experience; (3) the impact of habit and routine on the ways of experiencing the daily use of medications; and (4) the contribution of the concept of existential feelings to this experience and its impact on patients’ decision-making. Therefore, the experience with the daily use of medications is a complex and multifaceted phenomenon that directs the decision-making process of patients, impacting health outcomes. |
format | Online Article Text |
id | pubmed-8006003 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80060032021-03-30 The Subjective Experience of Using Medications: What We Know and the Paths Forward de Almeida Nascimento, Yone Ramalho-de-Oliveira, Djenane Pharmacy (Basel) Commentary Medications can cause bodily changes, where the associated benefits and risks are carefully assessed based on the changes experienced in the phenomenal body. For this reason, the phenomenology of Merleau-Ponty is an important theoretical framework for the study of experience related to the daily use of medications. The aim of this study was to discuss the contribution of a recently developed framework of the general ways people can experience the daily use of medications—resolution, adversity, ambiguity, and irrelevance—and present reflections about the little-understood aspects of this experience. However, some issues raised throughout this article remain open and invite us to further exploration, such as (1) the coexistence of multiple ways of experiencing the use of medications, by the same individual, in a given historical time; (2) the cyclical structure of this experience; (3) the impact of habit and routine on the ways of experiencing the daily use of medications; and (4) the contribution of the concept of existential feelings to this experience and its impact on patients’ decision-making. Therefore, the experience with the daily use of medications is a complex and multifaceted phenomenon that directs the decision-making process of patients, impacting health outcomes. MDPI 2021-03-02 /pmc/articles/PMC8006003/ /pubmed/33801298 http://dx.doi.org/10.3390/pharmacy9010050 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Commentary de Almeida Nascimento, Yone Ramalho-de-Oliveira, Djenane The Subjective Experience of Using Medications: What We Know and the Paths Forward |
title | The Subjective Experience of Using Medications: What We Know and the Paths Forward |
title_full | The Subjective Experience of Using Medications: What We Know and the Paths Forward |
title_fullStr | The Subjective Experience of Using Medications: What We Know and the Paths Forward |
title_full_unstemmed | The Subjective Experience of Using Medications: What We Know and the Paths Forward |
title_short | The Subjective Experience of Using Medications: What We Know and the Paths Forward |
title_sort | subjective experience of using medications: what we know and the paths forward |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006003/ https://www.ncbi.nlm.nih.gov/pubmed/33801298 http://dx.doi.org/10.3390/pharmacy9010050 |
work_keys_str_mv | AT dealmeidanascimentoyone thesubjectiveexperienceofusingmedicationswhatweknowandthepathsforward AT ramalhodeoliveiradjenane thesubjectiveexperienceofusingmedicationswhatweknowandthepathsforward AT dealmeidanascimentoyone subjectiveexperienceofusingmedicationswhatweknowandthepathsforward AT ramalhodeoliveiradjenane subjectiveexperienceofusingmedicationswhatweknowandthepathsforward |